ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,794Medicare Part D Prescriptions Filled, Including Refills

Rank: 361 out of 3593

$1.12M Total Retail Price of All Prescriptions

Rank: 106 out of 3593

258 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 11,949 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

52% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

50 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
CRESTOR 737 672 1 21
DIOVAN 529 518 2 46
NEXIUM 415 387 3 36
AMLODIPINE BESYLATE 307 306 4 3
ADVAIR DISKUS 302 265 5 47
SINGULAIR 288 268 6 77
CLOPIDOGREL 281 257 7 30
TRILIPIX 262 223 8 233
DIGOXIN 261 259 9 58
METFORMIN HCL 251 212 10 6
PLAVIX 238 226 11 42
MELOXICAM 212 209 12 29
DEXILANT 211 206 13 222
OMEPRAZOLE 191 187 14 5
CLONIDINE HCL 191 174 14 41
RANITIDINE HCL 184 169 16 27
EXELON 182 178 17 123
ESCITALOPRAM OXALATE 164 161 18 71
CARVEDILOL 154 150 19 23
CILOSTAZOL 153 144 20 163
ZOLPIDEM TARTRATE 152 142 21 12
DIOVAN HCT 149 139 22 76
LEVOTHYROXINE SODIUM 147 120 23 4
TEKTURNA 140 121 24 379
TRICOR 130 117 25 130
MONTELUKAST SODIUM 124 111 26 151
METOPROLOL TARTRATE 117 115 27 8
ONGLYZA 114 100 28 221
LOVAZA 112 91 29 106
LANTUS SOLOSTAR 109 102 30 122
LUNESTA 103 102 31 332
NABUMETONE 101 77 32 251
BUSPIRONE HCL 100 100 33 156
SUCRALFATE 98 93 34 237
LIDODERM 96 84 35 78
ISOSORBIDE MONONITRATE ER 90 90 36 61
PROAIR HFA 89 78 37 54
MEGESTROL ACETATE 89 89 R 37 152
AZITHROMYCIN 88 80 39 34
ALLOPURINOL 88 71 39 35
VOLTAREN 85 84 41 85
IBUPROFEN 85 85 41 43
DOXAZOSIN MESYLATE 84 78 43 63
NITROGLYCERIN PATCH 84 84 43 212
DONEPEZIL HCL 79 79 45 31
SPIRONOLACTONE 77 71 46 86
TAMSULOSIN HCL 77 71 46 33
FUROSEMIDE 76 75 48 9
BYSTOLIC 71 56 49 182
CLOTRIMAZOLE-BETAMETHASONE 66 60 50 94
WARFARIN SODIUM 66 66 50 18
ACTONEL 66 66 50 197
EXFORGE 65 54 53 214
LYRICA 65 50 53 105
LOSARTAN POTASSIUM 65 55 53 14
NATEGLINIDE 64 50 56 345
NASONEX 62 60 57 192
BENICAR 62 62 57 131
SIMVASTATIN 61 61 59 1
ATORVASTATIN CALCIUM 60 49 60 15
NAMENDA 58 58 61 50
QUETIAPINE FUMARATE 58 58 61 89
CELEBREX 57 57 63 100
ENALAPRIL MALEATE 57 54 63 38
SURE COMFORT 56 56 65 159
AVODART 55 55 66 180
METOPROLOL SUCCINATE 54 54 67 19
NITROSTAT 54 54 67 224
ACTOS 53 46 69 133
NAPROXEN 53 52 69 68
LACTULOSE 50 50 71 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 12, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.